Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.
Arechavala-Gomeza V, Kinali M, Feng L, Guglieri M, Edge G, Main M, Hunt D, Lehovsky J, Straub V, Bushby K, et al. Neuromuscul Disord. 2010 May; 20(5):295-301. Epub 2010 Apr 14.